genvec inc
(GNVC:Consolidated Issue listed on NASDAQ Capital Market)

Executive Profile*

Background*

Ms. Cynthia L. Collins has been the Chief Executive Officer and President of GenVec, Inc. since May 23, 2012. Ms. Collins served as Group Vice President of Cellular Analysis Business Group at Beckman Coulter Inc. from May 21, 2007 to 2011. She joined Beckman Coulter from Sequoia Pharmaceuticals, Inc., where she served as Chief Executive Officer. She served as the President of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development ... and commercialization of molecular diagnostic microarray products. She spent over 17 years at Baxter Healthcare in a variety of executive roles, including President of Global Oncology and Vice President of Strategy and Portfolio Management of BioScience, and six years with Abbott Laboratories in a series of operational assignments. She has been a Director of Biohealth Innovation since February 11, 2013 and GenVec, Inc. since May 23, 2012. Ms. Collins received her undergraduate degree in microbiology in 1980 from the University of Illinois and her MBA from the University of Chicago Graduate School of Business in 1988.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GNVC:US	$0.42 USD	--

COMPETITOR COMPENSATION